Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Global Macro Monitor
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Global Risk Monitor: Week in Review – March 21

% of readers think this story is Fact. Add your two cents.


Key Observations:

  • U.S. stock indexes broke multi-week losing streaks but remain in correction territory. Value sectors like Utilities and Energy outperformed as investors rotated out of large-cap tech amid rising tariff uncertainty and mixed economic data.
  • The Federal Reserve held rates steady and signaled cautious optimism. Despite lowering 2025 GDP projections and raising inflation estimates, Chair Powell emphasized that tariff effects may be “transitory,” contributing to a midweek market rebound.
  • Retail and manufacturing data painted a mixed picture of the U.S. economy. February retail sales rose just 0.2%, while the Empire State Manufacturing Survey showed declining optimism, contrasting with stronger housing starts and control group sales.
  • European markets gained slightly, bolstered by fiscal hopes but tempered by tariff concerns. The ECB warned U.S. tariffs could cut eurozone GDP by up to 0.5%, while the Swiss National Bank cut rates, signaling diverging policy paths across Europe.
  • Asia’s outlook is mixed with Japan steady, China stabilizing, and emerging Asia vulnerable. Japan’s BoJ maintained rates, citing stable inflation and wage dynamics, while China’s strong retail and industrial data were offset by persistent property sector weakness.
  • Tariff risks remain the key wildcard across global markets. With U.S. tariff announcements expected on April 2, trade tensions could escalate, impacting inflation and growth projections worldwide, especially in Europe and emerging Asia.
  • Investors brace for a data-heavy week to gauge consumer strength and inflation. Key releases—including PMIs, GDP, and the PCE price index—will help clarify whether current macro uncertainty signals a temporary slowdown or a deeper structural concern.

Markets

U.S. equities ended the week with modest gains, snapping multi-week losing streaks across the S&P 500, Nasdaq, and Dow. The S&P 500 rose 0.1%, while the Nasdaq gained 0.5%. However, the underlying trend remains cautious, as major indexes recently entered correction territory. Notably, large-cap tech stocks underperformed again, dragging down the Nasdaq, while value stocks—especially in Utilities, Energy, and Consumer Staples—continued to outperform growth.

The Russell 2000 outperformed other indexes, despite ongoing volatility. Meanwhile, Treasury yields fell, with the 2-year yield down to 3.95% and the 10-year holding at 4.25%, driven by dovish Fed projections.

Globally, European markets posted mild gains, with the STOXX Europe 600 up 0.56%. The UK’s FTSE 100 and Italy’s FTSE MIB also rose, but Germany’s DAX slipped. Japanese equities rallied, with the Nikkei 225 gaining 1.68% on the back of foreign investor demand and BoJ’s policy hold. Chinese markets, in contrast, declined despite better-than-expected retail sales and industrial output.

In emerging markets, Turkey faced volatility following political turmoil, while Brazil’s central bank raised rates again but hinted at a smaller hike ahead. Cryptocurrencies moved in line with equities, and gold extended its rally, signaling investor hedging.

Economics

The U.S. economic landscape remains mixed. Retail sales grew just 0.2% in February, below forecasts, while housing starts surged by 11.2% to 1.5 million units. The Fed left interest rates unchanged at 4.25%–4.5% but lowered GDP growth forecasts and raised inflation projections. Fed Chair Powell’s use of the term “transitory” regarding tariff-related inflationary effects reassured markets, though uncertainty remains elevated.  Nevertheless, credit spreads came in during the week and the Russell outperformed signaling the markets are not too worried about a recession.

Inflationary concerns persist globally. The ECB’s Christine Lagarde warned that retaliatory tariffs could raise eurozone inflation by 0.5%, while the ECB is expected to cut rates in April and June. The Swiss National Bank cut its rate to 0.25%, while the BoE and Sweden’s Riksbank held rates steady, reflecting uncertainty over inflation trajectories.

Japan’s inflation remains sticky, with February’s core CPI at 3.0%. The BoJ maintained its rate but flagged potential rate hikes if wage-price dynamics persist. Meanwhile, China’s data beat expectations, with retail sales and fixed asset investment rising, but property development continued to decline, and unemployment rose to 5.4%.

Emerging Asia faces GDP downgrades due to a harsher U.S. tariff outlook, though China and Hong Kong were spared. Monetary easing is expected across major Asian central banks.

Week Ahead

Markets face a pivotal week with a full slate of economic data. Key U.S. indicators include PMIs (Monday), Consumer Confidence and New Home Sales (Tuesday), Durable Goods Orders and GDP (Wednesday–Thursday), and the PCE inflation report (Friday). These will be closely watched for signs of resilience or weakness in consumer activity and inflation pressures, particularly amid escalating tariff risks.

Technically, the S&P 500 struggles to reclaim the 5,700 resistance level and shows signs of a bear flag, suggesting potential downside. Market breadth is improving, yet momentum remains fragile.

Volatility indicators suggest some easing in hedging activity, which could set the stage for a gradual recovery—more of a “U” bottom than a sharp rebound. With tariff announcements expected by April 2 and geopolitical developments in focus, investor positioning may turn defensive. Expect modest risk appetite amid heightened macro uncertainty.


Source: https://global-macro-monitor.com/2025/03/22/global-risk-monitor-week-in-review-march-21/


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.